RxDoctor Payments Data

Mouhammad Jumaa, MD

Neurology · Toledo, OHNPI 1124287164

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $20,345 of the $25,992 with a category attached, or 78.3%. 14 manufacturers reported payments, led by Perfuze Limited at 58.2% of the total. 2025 is the largest year on record at $17,783, 6.0 times the $2,985 reported in 2019.

$25,992in general payments, 2019–2025

Across 72 payments — averaging $361.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Perfuze Limited$15K
  • Microvention, Inc.$9K
  • Viz.ai, Inc.$439
  • Johnson & Johnson$359
  • Medtronic$284
  • Genentech, Inc.$221
  • plus $489 from 8 others
$1,106,494in research payments, 2019–2025

Across 175 payments — averaging $6322.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$692K
  • Medtronic$278K
  • Microvention, Inc.$118K
  • Sunovion Pharmaceuticals Inc.$16K
  • F. Hoffmann-la Roche AG$2K

What the payments were for

  • Speaking & faculty fees$2,0008%
  • Travel & lodging$20,34578%
  • Food & beverage$3,60014%
  • Education$470%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,992 in reported general payments places this provider in the 80th percentile of 702 neurology providers in Ohio.

See all neurology providers in Ohio

Medicare billing

Part B allowed, 2024
$143,968
Medicare patients
324
Services billed
849

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor37$16,385

Paid to pharmacies, not to this prescriber.

Other neurology in Toledo

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →